% | $
Quotes you view appear here for quick access.

CryoLife Inc. Message Board

  • dlhild Feb 13, 2010 10:48 PM Flag

    Point #7 - CRY & Medafor are not a good fit generally

    I'm guessing that 80% of the MPH market is in non-cardiac markets, places where CRY has no presence or knowledge. For example, China, Japan, OB-GYN, ENT, neuro, ortho, trama, general surgery, etc. Then remember CRY covers perhpas 50% of the cardiac market. The result is that maybe CRY is a 10% fit, but the obvious implication is that CRY is a 90% non-fit.

12.00+0.01(+0.08%)Jul 22 4:02 PMEDT